Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-20-001758
Filing Date
2020-08-18
Accepted
2020-08-18 19:44:59
Documents
1
Period of Report
2020-08-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 9300
  Complete submission text file 0001593968-20-001758.txt   10753
Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Brockstedt Dirk G. (Reporting) CIK: 0001635616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38997 | Film No.: 201115000

Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations